FDA Reverses Course On Convalescent Plasma Treatment For COVID-19
President Trump applauded the agency's emergency authorization during his press conference on Sunday.
CBS2's Ali Bauman reports
Doctor details risks of plasma treatment for COVID-19Doctors are reacting to the announcement by the Food and Drug Administration that it will authorize emergency use of convalescent plasma to treat COVID-19.
Convalescent Plasma studyBlood Assurance will study Convalescent Plasma as a Covid-19 treatment after the Trump Administration gave the go-ahead over the weekend.
FDA Chief Refutes Trump’s Baseless Claim That ‘Deep State’ Is Slowing Vaccine DevelopmentThe head of the FDA refuted baseless claims by President Trump that a “deep state” was preventing coronavirus vaccine development until after the election. Veuer’s Justin Kircher has the story.